|
|
Volumn 2, Issue 1, 2004, Pages 31-36
|
|
Is it ethical to use placebos in osteoporosis clinical trials?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
PLACEBO;
AGED;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
ETHICS;
FEMALE;
HOSPITALIZATION;
HUMAN;
INFORMED CONSENT;
MALE;
MIDDLE AGED;
MORTALITY;
OSTEOPOROSIS;
PATHOLOGIC FRACTURE;
POSTMENOPAUSE OSTEOPOROSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK ASSESSMENT;
SURVIVAL RATE;
TREATMENT OUTCOME;
UNITED STATES;
AGED;
DIPHOSPHONATES;
FEMALE;
FRACTURES, SPONTANEOUS;
HUMANS;
INFORMED CONSENT;
MALE;
MIDDLE AGED;
OSTEOPOROSIS;
OSTEOPOROSIS, POSTMENOPAUSAL;
PLACEBOS;
RANDOMIZED CONTROLLED TRIALS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
SURVIVAL RATE;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 23944512859
PISSN: 15441873
EISSN: None
Source Type: Journal
DOI: 10.1007/s11914-004-0012-4 Document Type: Review |
|
Times cited : (7)
|
|
References (38)
|
